Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 22.81%46.58B | 5.11%168.68B | 2.97%37.93B | -1.99%160.49B | -11.88%36.15B | 16.70%41.79B | 12.55%45.72B | -20.45%36.83B | 1.80%163.75B | 5.46%41.02B |
| Net interest income | 26.38%31.28B | 20.94%112.52B | 7.86%24.75B | -6.49%93.03B | 7.24%25.9B | -12.63%20.29B | -7.16%23.9B | -13.00%22.94B | -3.70%99.49B | -5.33%24.16B |
| -Total interest income | 38.09%40.81B | 29.19%137.79B | 11.40%29.55B | -2.25%106.66B | 8.31%29.64B | -12.32%23.28B | -2.39%27.21B | -2.88%26.53B | 4.12%109.11B | 5.55%27.36B |
| -Total interest expense | 98.44%9.53B | 85.51%25.28B | 34.02%4.8B | 41.57%13.63B | 16.37%3.73B | -10.19%3B | 55.06%3.31B | 279.96%3.58B | 548.15%9.63B | 680.54%3.21B |
| Non interest income | 16.12%15.3B | -16.73%56.17B | -5.11%13.18B | 4.97%67.45B | -39.26%10.24B | 70.78%21.5B | 46.66%21.82B | -30.31%13.89B | 11.68%64.26B | 26.03%16.86B |
| -Fees and commissions | 9.05%6.9B | 2.08%26.6B | 3.03%6.32B | 1.18%26.06B | -3.04%6.83B | -6.24%5.55B | 4.56%7.55B | 10.00%6.14B | 6.65%25.76B | 10.27%7.04B |
| -Including:Fees and commission income | 1.82%10.54B | 4.05%42.82B | 5.42%10.35B | 2.21%41.16B | 2.09%11.09B | 0.65%9.67B | 0.60%10.57B | 5.80%9.82B | 1.66%40.27B | 5.99%10.86B |
| -Including:Fees and commission expense | -9.54%3.64B | 7.45%16.22B | 9.40%4.03B | 4.04%15.09B | 11.54%4.26B | 11.66%4.13B | -8.08%3.03B | -0.54%3.68B | -6.13%14.51B | -1.09%3.82B |
| -Net trading income | -34.77%227M | 17.93%1.24B | 82.20%348M | 22.56%1.05B | 262.96%392M | 340.00%264M | -35.11%207M | -48.79%191M | -47.14%860M | -68.70%108M |
| -Total other operating income | 25.71%8.18B | -29.80%28.32B | -13.92%6.51B | 7.16%40.34B | -68.88%3.02B | 137.20%15.69B | 91.62%14.07B | -45.91%7.56B | 18.53%37.64B | 46.08%9.71B |
| Credit losses provision | 843.85%6.65B | -207.71%-894M | -93.55%830M | |||||||
| Operating expense | 0.55%26.47B | -20.05%110.41B | -10.47%26.33B | 1.16%138.1B | -5.44%33.59B | 26.00%36.08B | 11.16%39.03B | -21.08%29.41B | 16.00%136.52B | 35.64%35.52B |
| Selling and administrative expenses | -0.24%21.59B | -1.86%86.14B | 1.32%21.65B | 4.89%87.77B | 11.31%22.87B | 3.73%21.56B | 4.08%21.98B | 0.61%21.37B | -4.11%83.68B | -3.99%20.55B |
| -General and administrative expense | -0.24%21.59B | -1.86%86.14B | 1.32%21.65B | 4.89%87.77B | 11.31%22.87B | 3.73%21.56B | 4.08%21.98B | 0.61%21.37B | -4.11%83.68B | -3.99%20.55B |
| Other operating expenses | 4.21%4.88B | -51.77%24.27B | -41.80%4.68B | -4.75%50.33B | -28.41%10.72B | 84.95%14.52B | 21.85%17.05B | -49.82%8.04B | 73.70%52.84B | 212.81%14.97B |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 89.57%-72M | -16.02%2.12B | -576.47%-690M | 482.12%2.52B | -214.47%-717M | 189.89%160M | 1,622.01%3.18B | -126.67%-102M | -122.36%-660M | -106.94%-228M |
| Less:Other special charges | -97.80%9M | 1.06%-2.91B | 8,100.00%410M | -885.56%-2.94B | 117.11%495M | -450.77%-228M | -5,450.00%-3.21B | -76.19%5M | 111.11%374M | 106.38%228M |
| Less:Write off | -77.50%63M | 89.66%789M | 188.66%280M | 45.45%416M | --222M | -39.82%68M | -80.54%29M | 304.17%97M | -30.92%286M | --0 |
| Income before tax | 83.67%20.04B | 108.30%53.74B | 48.98%10.91B | 0.26%25.8B | -38.32%2.74B | -16.13%5.87B | 86.24%9.87B | -18.57%7.32B | -22.57%25.73B | 42.39%4.44B |
| Income tax | 73.52%5.79B | 472.88%14.36B | 22.30%3.34B | -39.94%2.51B | 119.91%593M | -58.95%924M | -202.96%-1.74B | -15.18%2.73B | -66.73%4.17B | -219.83%-2.98B |
| Net income | 88.15%14.25B | 69.06%39.38B | 64.82%7.57B | 8.05%23.29B | -71.07%2.15B | 4.17%4.95B | 221.35%11.6B | -20.46%4.59B | 4.22%21.56B | 1,072.35%7.42B |
| Net income continuous operations | 88.14%14.25B | 69.06%39.38B | 64.81%7.57B | 8.05%23.29B | -71.08%2.15B | 4.17%4.95B | 221.35%11.6B | -20.46%4.6B | 4.21%21.56B | 1,072.20%7.42B |
| Noncontrolling interests | -73.21%30M | 25.51%305M | 103.64%112M | 100.83%243M | 376.47%81M | 137.50%57M | 47.06%50M | 19.57%55M | -23.42%121M | 206.25%17M |
| Net income attributable to the company | 90.59%14.22B | 69.52%39.07B | 64.37%7.46B | 7.53%23.05B | -72.10%2.07B | 3.49%4.89B | 223.10%11.55B | -20.80%4.54B | 4.43%21.44B | 1,040.83%7.4B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 90.59%14.22B | 69.52%39.07B | 64.37%7.46B | 7.53%23.05B | -72.10%2.07B | 3.49%4.89B | 223.10%11.55B | -20.80%4.54B | 4.43%21.44B | 1,040.83%7.4B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 93.51%116.3 | 76.03%311.56 | 68.39%60.1 | 11.19%176.99 | -74.88%13.57 | 6.86%39.41 | 275.83%88.32 | -20.30%35.69 | 7.94%159.18 | 5,356.57%54.02 |
| Diluted earnings per share | 93.55%115.84 | 76.02%310.29 | 68.31%59.85 | 11.13%176.28 | -74.93%13.5 | 6.78%39.24 | 275.66%87.98 | -20.30%35.56 | 7.95%158.63 | 5,450.52%53.84 |
| Dividend per share | 0 | 25.00%50 | 0 | 8.11%40 | 8.11%40 | 0 | 0 | 0 | 5.71%37 | 5.71%37 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |